Search

Your search keyword '"Parascandalo, Jenna"' showing total 28 results
Start Over Author "Parascandalo, Jenna"
28 results on '"Parascandalo, Jenna"'

1. Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Published
2023
Full Text
View/download PDF

5. Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Freeman, Karla, additional, Ali, Abbas, additional, Clark, Rebecca, additional, Shah, Nikki, additional, Awan, Amen, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Dore Brown, Naomi, additional, Jurcic-Vrataric, Jane, additional, Colwill, Kiska, additional, Dragos, Steven, additional, Borhan, Sayem, additional, Risdon, Cathy, additional, Siu, Henry, additional, Farrell, Barbara, additional, and Trimble, Johanna, additional

Published
2023
Full Text
View/download PDF

6. sj-docx-3-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-3-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

7. Additional file 2 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 2. Consort extension for pilot and feasibility trials checklist.

Published
2023
Full Text
View/download PDF

8. Additional file 4 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 4: Results of patient outcome measures. Fig. 3. EQD5 and SF36-V1 quality of life scales. Fig. 4. WHODAS, psychological distress, mobility fatigue, sleep quality. Fig. 5. Patient enablement, cognition, and nutrition. Fig. 6. Number of medications. Fig. 7. Side effects at 6-months.

Published
2023
Full Text
View/download PDF

9. sj-docx-2-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-2-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

10. sj-docx-1-jpx-10.1177_23743735231174762 - Supplemental material for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway

Author

Mangin, Dee, Lamarche, Larkin, Freeman, Karla, Ali, Abbas, Clark, Rebecca, Shah, Nikki, Awan, Amen, Langevin, Jessica, Parascandalo, Jenna, Dore Brown, Naomi, Jurcic-Vrataric, Jane, Colwill, Kiska, Dragos, Steven, Borhan, Sayem, Risdon, Cathy, Siu, Henry, Farrell, Barbara, and Trimble, Johanna

Subjects
111708 Health and Community Services, Medicine, FOS: Health sciences
Abstract

Supplemental material, sj-docx-1-jpx-10.1177_23743735231174762 for Linking Patients’ Goals and Priorities to Recommendations for Medication Changes in a Polypharmacy-Focused Structured Clinical Pathway by Dee Mangin, Larkin Lamarche, Karla Freeman, Abbas Ali, Rebecca Clark, Nikki Shah, Amen Awan, Jessica Langevin, Jenna Parascandalo, Naomi Dore Brown, Jane Jurcic-Vrataric, Kiska Colwill, Steven Dragos, Sayem Borhan, Cathy Risdon, Henry Siu, Barbara Farrell and Johanna Trimble in Journal of Patient Experience

Published
2023
Full Text
View/download PDF

11. Additional file 3 of Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Ali, Abbas, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Brown, Naomi Dore, Farrell, Barbara, Freeman, Karla, Frizzle, Kristina, Garrison, Scott R., Gillett, James, Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, Parascandalo, Jenna, Richardson, Julie, Risdon, Cathy, Sherifali, Diana, Siu, Henry, Borhan, Sayem, Templeton, Jeffery A., Thabane, Lehana, and Trimble, Johanna

Abstract

Additional file 3. TIDier Checklist.

Published
2023
Full Text
View/download PDF

12. Evaluation of a community paramedicine health promotion and lifestyle risk assessment program for older adults who live in social housing: a cluster randomized trial

Author

Agarwal, Gina, Angeles, Ricardo, Pirrie, Melissa, McLeod, Brent, Marzanek, Francine, Parascandalo, Jenna, and Thabane, Lehana

Subjects
Diabetes mellitus -- Diagnosis, Hypertension -- Diagnosis, Health risk assessment -- Analysis, Cardiovascular diseases -- Patient outcomes, Health promotion -- Planning, Company business planning, Health
Abstract

BACKGROUND: Low-income older adults who live in subsidized housing have higher mortality and morbidity. We aimed to determine if a community paramedicine program--in which paramedics provide health care services outside of the traditional emergency response--reduced the number of ambulance calls to subsidized housing for older adults. METHODS: We conducted an open-label pragmatic cluster-randomized controlled trial (RCT) with parallel intervention and control groups in subsidized apartment buildings for older adults. We selected 6 buildings using predefined criteria, which we then randomly assigned to intervention (Community Paramedicine at Clinic [CP@ clinic] for 1 yr) or control (usual health care) using computer-generated paired randomization. CP@clinic is a paramedicled, community-based health promotion program to prevent diabetes, cardiovascular disease and falls for residents 55 years of age and older. The primary outcome was building-level mean monthly ambulance calls. Secondary outcomes were individual-level changes in blood pressure, health behaviours and risk of diabetes assessed using the Canadian Diabetes Risk Questionnaire. We analyzed the data using generalized estimating equations and hierarchical linear modelling. RESULTS: The 3 intervention and 3 control buildings had 455 and 637 residents, respectively. Mean monthly ambulance calls in the intervention buildings (3.11 [standard deviation (SD) 1.30] calls per 100 units/mo) was significantly lower (-0.88, 95% confidence interval [CI] -0.45 to -1.30) than in control buildings (3.99 [SD 1.17] calls per 100 units/mo), when adjusted for baseline calls and building pairs. Survey participation was 28.4% (n = 129) and 20.3% (n = 129) in the intervention and control buildings, respectively. Residents living in the intervention buildings showed significant improvement compared with those living in control buildings in quality-adjusted life years (QALYs) (mean difference 0.09, 95% CI 0.01 to 0.17) and ability to perform usual activities (odds ratio 2.6, 95% CI 1.2 to 5.8). Those who received the intervention had a significant decrease in systolic (mean change 5.0, 95% CI 1.0 to 9.0) and diastolic (mean change 4.8, 95% CI 1.9 to 7.6) blood pressure. INTERPRETATION: A paramedic-led, community-based health promotion program (CP@clinic) significantly lowered the number of ambulance calls, improved QALYs and ability to perform usual activities, and lowered systolic blood pressure among older adults living in subsidized housing. Trial registration: Clinicaltrials.gov, no. NCT02152891, In 2010, chronic disease accounted for 89% of worldwide deaths, mostly in older adults (65 years of age and older). (1) It causes a substantial burden on health care systems, [...]

Published
2018
Full Text
View/download PDF

13. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, primary, Lamarche, Larkin, additional, Agarwal, Gina, additional, Banh, Hoan Linh, additional, Dore Brown, Naomi, additional, Cassels, Alan, additional, Colwill, Kiska, additional, Dolovich, Lisa, additional, Farrell, Barbara, additional, Garrison, Scott, additional, Gillett, James, additional, Griffith, Lauren E., additional, Holbrook, Anne, additional, Jurcic-Vrataric, Jane, additional, McCormack, James, additional, O’Reilly, Daria, additional, Raina, Parminder, additional, Richardson, Julie, additional, Risdon, Cathy, additional, Savelli, Mat, additional, Sherifali, Diana, additional, Siu, Henry, additional, Tarride, Jean-Éric, additional, Trimble, Johanna, additional, Ali, Abbas, additional, Freeman, Karla, additional, Langevin, Jessica, additional, Parascandalo, Jenna, additional, Templeton, Jeffrey A., additional, Dragos, Steven, additional, Borhan, Sayem, additional, and Thabane, Lehana, additional

Published
2021
Full Text
View/download PDF

17. Additional file 6 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 6. PDF. Site fidelity to TAPER-RCT model. The checklist that will be used to measure a site’s adherence to the TAPER-RCT protocol.

18. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

19. Additional file 2 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 2. PDF. TIDier Checklist.

20. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

21. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan L., Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O���Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-��ric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Background Polypharmacy in older adults can be associated with negative outcomes including falls, impaired cognition, reduced quality of life, and general and functional decline. It is not clear to what extent these are reversible if the number of medications is reduced. Primary care does not have a systematic approach for reducing inappropriate polypharmacy, and there are few, if any, approaches that account for the patient���s priorities and preferences. The primary objective of this study is to test the effect of TAPER (Team Approach to Polypharmacy Evaluation and Reduction), a structured operationalized clinical pathway focused on reducing inappropriate polypharmacy. TAPER integrates evidence tools for identifying potentially inappropriate medications, tapering, and monitoring guidance and explicit elicitation of patient priorities and preferences. We aim to determine the effect of TAPER on the number of medications (primary outcome) and health-related outcomes associated with polypharmacy in older adults. Methods We designed a multi-center randomized controlled trial, with the lead implementation site in Hamilton, Ontario. Older adults aged 70 years or older who are on five or more medications will be eligible to participate. A total of 360 participants will be recruited. Participants will be assigned to either the control or intervention arm. The intervention involves a comprehensive multidisciplinary medication review by pharmacists and physicians in partnership with patients. This review will be focused on reducing medication burden, with the assumption that this will reduce the risks and harms of polypharmacy. The control group is a wait list, and control patients will be given appointments for the TAPER intervention at a date after the final outcome assessment. All patients will be followed up and outcomes measured in both groups at baseline and 6 months. Discussion Our trial is unique in its design in that it aims to introduce an operationalized structured clinical pathway aimed to reduce polypharmacy in a primary care setting while at the same time recording patient���s goals and priorities for treatment. Trial registration Clinical Trials.gov NCT02942927. First registered on October 24, 2016.

22. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

23. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

24. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

25. Additional file 4 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
fungi, 3. Good health
Abstract

Additional file 4. PDF. Quantitative patient outcomes measure descriptions. A list of the primary and secondary outcomes, descriptions of the measures and the psychometric properties of the measures.

26. Additional file 3 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, 3. Good health
Abstract

Additional file 3. PDF. TaperMD. A list of the questions on the TaperMD web-based platform.

27. Additional file 5 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 5. PDF. Data collection schedule. A diagram outlining the proposed timeline of the study.

28. Additional file 1 of Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Author

Mangin, Dee, Lamarche, Larkin, Agarwal, Gina, Banh, Hoan Linh, Dore Brown, Naomi, Cassels, Alan, Colwill, Kiska, Dolovich, Lisa, Farrell, Barbara, Garrison, Scott, Gillett, James, Griffith, Lauren E., Holbrook, Anne, Jurcic-Vrataric, Jane, McCormack, James, O’Reilly, Daria, Raina, Parminder, Richardson, Julie, Risdon, Cathy, Savelli, Mat, Sherifali, Diana, Siu, Henry, Tarride, Jean-Éric, Trimble, Johanna, Ali, Abbas, Freeman, Karla, Langevin, Jessica, Parascandalo, Jenna, Templeton, Jeffrey A., Dragos, Steven, Borhan, Sayem, and Thabane, Lehana

Subjects
3. Good health
Abstract

Additional file 1. PDF. Spirit 2013 Checklist.

Catalog

Books, media, physical & digital resources
See catalog results